MOTS-c is a short peptide that cells can make from mitochondrial DNA. Researchers study it because mitochondria (the parts of cells that help make energy) also send chemical messages, and MOTS-c is one of those messages.
This article is educational. CoreVials MOTS-c is for laboratory research only, not for human or animal use.
What is MOTS-c?
MOTS-c stands for "mitochondrial open reading frame of the 12S rRNA type-c." In plain English: it is a 16-amino-acid peptide coded inside mitochondrial DNA, not the DNA in the cell nucleus.
That matters because most peptides people hear about are coded by nuclear genes. MOTS-c is part of a smaller family called mitochondrial-derived peptides.
What do labs think it does?
In cell and animal work, MOTS-c is linked to energy stress signals. A key pathway discussed in the literature is AMPK (a fuel-sensing switch inside cells).
When researchers describe MOTS-c, they often connect it to:
- How muscle cells handle glucose
- How the body responds to metabolic stress
- Signals that rise with exercise in some studies
Think of it like a note mitochondria send when energy balance is under pressure. That analogy is imperfect, but it helps beginners remember the concept.
What did the early mouse studies find?
A major 2015 paper from Lee and colleagues reported that MOTS-c helped maintain metabolic balance in mice and reduced diet-related obesity and insulin resistance in those models.
Later reviews describe MOTS-c work across stress, metabolism, and aging-related research questions. Reviews are useful maps. They are not the same as a finished human medicine story.
What about human data?
Human work is still thinner than the mouse literature. Some studies measure circulating MOTS-c and look for links with insulin sensitivity, body composition, or related markers.
Those associations are not always the same across groups (for example, findings can differ by sex or obesity status in published reports). Observational links also do not prove that giving MOTS-c as a research compound will create the same pattern.
How does this relate to other metabolic research?
Readers who follow metabolic peptides often ask how MOTS-c compares with incretin research tools such as retatrutide or tirzepatide. Those compounds act on different receptor systems.
MOTS-c research is mainly about mitochondrial signaling and metabolic stress pathways. Incretin research is mainly about gut-hormone receptor pathways. Labs may study them in different experimental designs. That does not mean they are interchangeable.
For related reading, see NAD+ research overview and autophagy research explained.
What should beginners remember?
- MOTS-c is mitochondria-coded, not a typical nuclear-gene peptide.
- Most strong causal data so far come from preclinical models.
- Human papers often measure blood levels or associations, not large outcome trials of exogenous MOTS-c.
- Research materials are not consumer supplements or medicines.
References
- Lee, C., et al. (2015). The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metabolism. Read the study
- Kim, S.J., et al. (2019). The mitochondrial-derived peptide MOTS-c is a regulator of plasma metabolites and enhances insulin sensitivity. Physiological Reports. Read the study
- Mo, Y., et al. (2023). Mitochondria-derived peptide MOTS-c: effects and mechanisms related to stress, metabolism and aging. Journal of Translational Medicine. Read the review
